Skip to content

Cameco

US · CCJ #575 by market cap Listed 1970
58.00 -3.42 -5.57%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Valuation each multiple against its own 5-year range

P/B ratio 5.01 In line with history 62nd percentile
5-year average 4.97 · #11 of 12 in Uranium
P/E ratio 91.34 Cheap vs history 25th percentile
5-year average 96.23 · forward 37.37 · #3 of 3 in Uranium
P/S ratio 10.41 In line with history 47th percentile
5-year average 11.33 · forward 9.69 · #5 of 9 in Uranium

Vs. peers Uranium

Company Market cap P/E (TTM) P/B Div yield
Cameco (CCJ) 25.26B 91.34 5.01 0.29%
NexGen Energy (NXE) 4.40B -41.83 3.27 0.00%
Uranium Energy (UEC) 2.63B -18.93 1.91 0.00%
Centrus Energy (LEU) 1.68B 24.16 1.52 0.00%
Denison Mines (DNN) 1.52B -40.00 5.83 0.00%
Energy Fuels (UUUU) 1.31B -10.33 1.37 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value52.76 Economic moatNarrow UncertaintyVery High

Trading 9.0% above Morningstar's fair value estimate.

Fair value

Cameco Corp receives a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 16% premium over our quantitative fair value estimate of $52.76 per share; however, this estimate should be taken with a pinch of salt due to its very high uncertainty rating.

The firm's lack of profitability weakens our estimated valuation. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. Reflecting the firm's profitability is its sales yield of 8.1%, which ranks in the bottom 10% globally. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which contributes to our view that shares are overvalued.

The company's valuation metrics are an additional cause for concern. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 16.5%, for example, ranks in the bottom 20% compared with peers globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which further promotes our unfavorable price/fair value ratio.

Economic moat

The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.

Cameco discussion 0 comments

Add a comment